• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞在急性和慢性炎症性肺病发展中的作用。

The Role of Macrophages in the Development of Acute and Chronic Inflammatory Lung Diseases.

机构信息

Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Chungbuk, Cheongju 28116, Korea.

Department of Pharmacology, College of Medicine, Kangwon National University, Chuncheon 24341, Korea.

出版信息

Cells. 2021 Apr 14;10(4):897. doi: 10.3390/cells10040897.

DOI:10.3390/cells10040897
PMID:33919784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8070705/
Abstract

Macrophages play an important role in the innate and adaptive immune responses of organ systems, including the lungs, to particles and pathogens. Cumulative results show that macrophages contribute to the development and progression of acute or chronic inflammatory responses through the secretion of inflammatory cytokines/chemokines and the activation of transcription factors in the pathogenesis of inflammatory lung diseases, such as acute lung injury (ALI), acute respiratory distress syndrome (ARDS), ARDS related to COVID-19 (coronavirus disease 2019, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)), allergic asthma, chronic obstructive pulmonary disease (COPD), and idiopathic pulmonary fibrosis (IPF). This review summarizes the functions of macrophages and their associated underlying mechanisms in the development of ALI, ARDS, COVID-19-related ARDS, allergic asthma, COPD, and IPF and briefly introduces the acute and chronic experimental animal models. Thus, this review suggests an effective therapeutic approach that focuses on the regulation of macrophage function in the context of inflammatory lung diseases.

摘要

巨噬细胞在包括肺部在内的器官系统的固有和适应性免疫反应中发挥重要作用,以应对颗粒和病原体。累积的结果表明,巨噬细胞通过分泌炎症细胞因子/趋化因子和激活转录因子,在炎症性肺病(如急性肺损伤(ALI)、急性呼吸窘迫综合征(ARDS)、与 COVID-19 相关的 ARDS(由严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起)、过敏性哮喘、慢性阻塞性肺疾病(COPD)和特发性肺纤维化(IPF))的发病机制中,促进急性或慢性炎症反应的发展和进展。本综述总结了巨噬细胞的功能及其相关潜在机制在 ALI、ARDS、COVID-19 相关 ARDS、过敏性哮喘、COPD 和 IPF 中的作用,并简要介绍了急性和慢性实验动物模型。因此,本综述提出了一种有效的治疗方法,即专注于在炎症性肺病背景下调节巨噬细胞功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d93d/8070705/0c528496406d/cells-10-00897-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d93d/8070705/01bd803a2094/cells-10-00897-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d93d/8070705/dc5a3c974934/cells-10-00897-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d93d/8070705/c88edcf97e88/cells-10-00897-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d93d/8070705/0c528496406d/cells-10-00897-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d93d/8070705/01bd803a2094/cells-10-00897-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d93d/8070705/dc5a3c974934/cells-10-00897-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d93d/8070705/c88edcf97e88/cells-10-00897-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d93d/8070705/0c528496406d/cells-10-00897-g004.jpg

相似文献

1
The Role of Macrophages in the Development of Acute and Chronic Inflammatory Lung Diseases.巨噬细胞在急性和慢性炎症性肺病发展中的作用。
Cells. 2021 Apr 14;10(4):897. doi: 10.3390/cells10040897.
2
Autophagy Augmentation to Alleviate Immune Response Dysfunction, and Resolve Respiratory and COVID-19 Exacerbations.自噬增强以减轻免疫反应功能障碍,并解决呼吸和 COVID-19 恶化问题。
Cells. 2020 Aug 24;9(9):1952. doi: 10.3390/cells9091952.
3
The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome.巨噬细胞在 SARS-CoV-2 相关急性呼吸窘迫综合征发病机制中的作用。
Front Immunol. 2021 May 10;12:682871. doi: 10.3389/fimmu.2021.682871. eCollection 2021.
4
Functional Evidence of Pulmonary Extracellular Vesicles in Infectious and Noninfectious Lung Inflammation.肺细胞外囊泡在感染性和非感染性肺部炎症中的功能证据。
J Immunol. 2018 Sep 1;201(5):1500-1509. doi: 10.4049/jimmunol.1800264. Epub 2018 Jul 11.
5
SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis.SARS-CoV-2 感染引发成纤维细胞增生性巨噬细胞反应和肺纤维化。
Cell. 2021 Dec 22;184(26):6243-6261.e27. doi: 10.1016/j.cell.2021.11.033. Epub 2021 Nov 27.
6
Angiotensin-converting enzyme 2 expression in COPD and IPF fibroblasts: the forgotten cell in COVID-19.COPD 和 IPF 成纤维细胞中的血管紧张素转换酶 2 表达:COVID-19 中被遗忘的细胞。
Am J Physiol Lung Cell Mol Physiol. 2021 Jan 1;320(1):L152-L157. doi: 10.1152/ajplung.00455.2020. Epub 2020 Oct 28.
7
Macrophage polarization and its impact on idiopathic pulmonary fibrosis.巨噬细胞极化及其对特发性肺纤维化的影响。
Front Immunol. 2024 Jul 26;15:1444964. doi: 10.3389/fimmu.2024.1444964. eCollection 2024.
8
Virus-Induced Acute Respiratory Distress Syndrome Causes Cardiomyopathy Through Eliciting Inflammatory Responses in the Heart.病毒诱导的急性呼吸窘迫综合征通过在心脏中引发炎症反应引起心肌病。
Circulation. 2024 Jul 2;150(1):49-61. doi: 10.1161/CIRCULATIONAHA.123.066433. Epub 2024 Mar 20.
9
Distinct severe acute respiratory syndrome coronavirus-induced acute lung injury pathways in two different nonhuman primate species.两种不同灵长类动物中 SARS-CoV 诱导的急性肺损伤的不同途径。
J Virol. 2011 May;85(9):4234-45. doi: 10.1128/JVI.02395-10. Epub 2011 Feb 16.
10
The role of macrophages in obstructive airways disease: chronic obstructive pulmonary disease and asthma.巨噬细胞在阻塞性气道疾病中的作用:慢性阻塞性肺疾病和哮喘。
Cytokine. 2013 Dec;64(3):613-25. doi: 10.1016/j.cyto.2013.09.010. Epub 2013 Sep 29.

引用本文的文献

1
Risk of remnant cholesterol and chronic obstructive pulmonary disease: a mendelian randomization study.残余胆固醇与慢性阻塞性肺疾病的风险:一项孟德尔随机化研究
J Thorac Dis. 2025 Jul 31;17(7):5122-5132. doi: 10.21037/jtd-24-1894. Epub 2025 Jul 25.
2
Analysis of immune characteristics and inflammatory mechanisms in COPD patients: a multi-layered study combining bulk and single-cell transcriptome analysis and machine learning.慢性阻塞性肺疾病患者的免疫特征与炎症机制分析:一项结合批量和单细胞转录组分析及机器学习的多层次研究
Front Med (Lausanne). 2025 Jul 21;12:1592802. doi: 10.3389/fmed.2025.1592802. eCollection 2025.
3

本文引用的文献

1
A Novel CD206 Targeting Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice.一种新型靶向 CD206 的肽抑制博来霉素诱导的小鼠肺纤维化。
Cells. 2023 Apr 26;12(9):1254. doi: 10.3390/cells12091254.
2
Macrophages in Lung Injury, Repair, and Fibrosis.肺损伤、修复和纤维化中的巨噬细胞。
Cells. 2021 Feb 18;10(2):436. doi: 10.3390/cells10020436.
3
Panaxydol attenuates ferroptosis against LPS-induced acute lung injury in mice by Keap1-Nrf2/HO-1 pathway.三七乙素通过 Keap1-Nrf2/HO-1 通路减轻 LPS 诱导的小鼠急性肺损伤中的铁死亡。
Saroglitazar Ameliorates Pulmonary Fibrosis Progression in Mice by Suppressing NF-κB Activation and Attenuating Macrophage M1 Polarization.
司格列他扎通过抑制NF-κB激活和减轻巨噬细胞M1极化改善小鼠肺纤维化进展。
Medicina (Kaunas). 2025 Jun 26;61(7):1157. doi: 10.3390/medicina61071157.
4
Significant Spontaneous Pneumomediastinum and Extensive Subcutaneous Emphysema in a COVID-19 Patient.一名新冠病毒肺炎患者出现大量自发性纵隔气肿和广泛皮下气肿
Reports (MDPI). 2024 Feb 19;7(1):15. doi: 10.3390/reports7010015.
5
Exercise's protective role in chronic obstructive pulmonary disease via modulation of M1 macrophage phenotype through the miR-124-3p/ERN1 axis.运动通过miR-124-3p/ERN1轴调节M1巨噬细胞表型在慢性阻塞性肺疾病中的保护作用。
Sci Prog. 2025 Jul-Sep;108(3):368504251360892. doi: 10.1177/00368504251360892. Epub 2025 Jul 17.
6
Cordycepin, lactoferrin, and Sargassum fusiforme polysaccharides protects against RSV via M2-like macrophage polarization.虫草素、乳铁蛋白和羊栖菜多糖通过M2样巨噬细胞极化对呼吸道合胞病毒具有保护作用。
Front Immunol. 2025 Jun 16;16:1576069. doi: 10.3389/fimmu.2025.1576069. eCollection 2025.
7
Polymethoxyflavones extracted from alleviate LPS-induced acute lung injury by ameliorating endoplasmic reticulum stress.从……中提取的多甲氧基黄酮通过改善内质网应激减轻脂多糖诱导的急性肺损伤。 (你提供的原文中“from”后面缺少具体内容)
Front Pharmacol. 2025 Jun 11;16:1544916. doi: 10.3389/fphar.2025.1544916. eCollection 2025.
8
Mechanisms of (Thunb.) Franch. Extract in Asthma Therapy: Oxidative Stress, Inflammation, and Gut Microbiota.(羌活) Franch. 提取物在哮喘治疗中的作用机制:氧化应激、炎症和肠道微生物群
Biology (Basel). 2025 Jun 19;14(6):731. doi: 10.3390/biology14060731.
9
BHLHE40 contributes to allergic asthma progression in mice through NRTN downregulation in macrophages.BHLHE40通过下调巨噬细胞中的NRTN促进小鼠过敏性哮喘的进展。
Commun Biol. 2025 Jun 4;8(1):863. doi: 10.1038/s42003-025-08288-1.
10
Inhibition of DLK1 regulates AT2 differentiation and alleviates established pulmonary fibrosis by upregulating TTF-1/CLDN6.抑制DLK1可通过上调TTF-1/CLDN6来调节II型肺泡上皮细胞(AT2)分化并减轻已形成的肺纤维化。
Respir Res. 2025 May 16;26(1):188. doi: 10.1186/s12931-025-03264-z.
J Transl Med. 2021 Mar 2;19(1):96. doi: 10.1186/s12967-021-02745-1.
4
Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections.对抗新冠病毒等肺部感染的潜在免疫纳米医学策略。
Nano Today. 2021 Feb;36:101051. doi: 10.1016/j.nantod.2020.101051. Epub 2020 Dec 4.
5
Molecular Insights into the MAPK Cascade during Viral Infection: Potential Crosstalk between HCQ and HCQ Analogues.病毒感染过程中 MAPK 级联的分子机制:HCQ 和 HCQ 类似物之间的潜在串扰。
Biomed Res Int. 2020 Dec 31;2020:8827752. doi: 10.1155/2020/8827752. eCollection 2020.
6
Botanical formulation, TADIOS, alleviates lipopolysaccharide (LPS)-Induced acute lung injury in mice via modulation of the Nrf2-HO-1 signaling pathway.植物配方 TADIOS 通过调节 Nrf2-HO-1 信号通路缓解脂多糖(LPS)诱导的小鼠急性肺损伤。
J Ethnopharmacol. 2021 Apr 24;270:113795. doi: 10.1016/j.jep.2021.113795. Epub 2021 Jan 7.
7
NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients.NF-κB 通路作为治疗危重症 COVID-19 患者的潜在靶点。
Front Immunol. 2020 Dec 10;11:598444. doi: 10.3389/fimmu.2020.598444. eCollection 2020.
8
Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019.以巨噬细胞为靶点作为2019冠状病毒病的一种治疗选择
Front Pharmacol. 2020 Oct 29;11:577571. doi: 10.3389/fphar.2020.577571. eCollection 2020.
9
Selection of animal models for COVID-19 research.用于新型冠状病毒肺炎研究的动物模型的选择。
Virusdisease. 2020 Dec;31(4):453-458. doi: 10.1007/s13337-020-00637-4. Epub 2020 Dec 2.
10
Macrophage metabolic reprogramming during chronic lung disease.慢性肺部疾病中巨噬细胞的代谢重编程。
Mucosal Immunol. 2021 Mar;14(2):282-295. doi: 10.1038/s41385-020-00356-5. Epub 2020 Nov 12.